Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

The Journal of Pharmaceutical and Biomedical Analysis, published by ELSEVIER and available in print and online formats, stands as a pivotal source of knowledge in the realms of Analytical Chemistry, Clinical Biochemistry, Drug Discovery, and Pharmaceutical Science. With an ISSN of 0731-7085 and an e-ISSN of 1873-264X, this journal is dedicated to publishing high-quality research that advances the understanding and development of analytical techniques in pharmaceuticals and biomedicine. The journal has earned a solid reputation, reflected in its Q2 category rankings across five distinct fields for 2023, and boasts impressive Scopus rankings, signaling its robust impact within the academic community. The Journal of Pharmaceutical and Biomedical Analysis serves as an essential resource for researchers, professionals, and students alike, providing actionable insights and fostering innovation that can directly influence future advancements in drug development and biomedical applications.

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.

Drug Testing and Analysis is a leading scholarly journal published by WILEY, dedicated to advancing the field of drug testing and analytical methods. With ISSN 1942-7603 and E-ISSN 1942-7611, this journal provides a platform for the latest research in Analytical Chemistry, Pharmaceutical Science, and Environmental Chemistry, holding a prestigious reputation reflected in its Q1 and Q2 rankings across various categories in 2023. The journal promotes high-impact studies that explore innovative methodologies, with a specific focus on pharmacological and toxicological analyses, making it an essential resource for researchers, professionals, and students concerned with drug efficacy, safety, and environmental impact. With a strong commitment to quality and relevance, Drug Testing and Analysis remains at the forefront of contemporary scientific inquiry, contributing significantly to both academic and practical advancements in the industry.

JOURNAL OF FOOD AND DRUG ANALYSIS, an esteemed publication in the realms of Food Science and Pharmacology, is published by DIGITAL COMMONS BEPRESS. With an impactful commitment to open access since 2013, this journal facilitates the dissemination of critical research findings, making them readily available to a global audience. Boasting a commendable Q2 ranking in both Food Science and Pharmacology, the journal occupies a prominent position in its respective categories, reflecting its quality and relevance in the field. Established in 1994, the journal has successfully converged its focus to encompass a wide range of topics related to the analysis of food and drugs, thereby providing valuable insights to researchers, practitioners, and students alike. With its indexed indicators in Scopus showcasing a strong performance—ranking #85 among 389 in Food Science and #108 among 313 in Pharmacology—it stands as a crucial platform for the advancement of knowledge and innovation. For those looking to stay abreast of pivotal developments in food safety and drug efficacy, JOURNAL OF FOOD AND DRUG ANALYSIS is an indispensable resource.

Separation Science Plus is an emerging academic journal dedicated to advancing the field of analytical chemistry and separation science. Published by WILEY-VCH Verlag GmbH, this journal provides a platform for researchers to disseminate high-quality studies and reviews that address innovative techniques and breakthroughs in separation methodologies. With its ISSN 2573-1815, the journal has made significant inroads since its inception in 2018, encompassing a convergence period until 2024. Despite currently holding a Q3 ranking in Analytical Chemistry and a Q4 ranking in Filtration and Separation, its dedication to publishing impactful research makes it a vital resource for professionals and students alike. The journal operates under the robust scholarly reputation of WILEY, which is known for its commitment to excellence in scientific communication. Researchers interested in the latest advancements in separation techniques will find Separation Science Plus an essential read, fostering the exchange of knowledge and facilitating greater understanding within this specialized field.

Journal of Pharmaceutical Analysis is a premier open-access journal published by ELSEVIER, dedicated to advancing the field of pharmaceutical sciences. Since its inception in 2011, this journal has become a vital resource for researchers, professionals, and students, with a focus on analytical chemistry, drug discovery, and electrochemistry, among other subjects. With an impressive impact factor reflected in its Q1 ranking across multiple categories such as Analytical Chemistry and Drug Discovery in 2023, it maintains a high standard in the dissemination of innovative research. The journal not only facilitates the sharing of significant findings but also promotes collaboration and discussion within the community, making a notable impact globally. Articles published in the Journal of Pharmaceutical Analysis are easily accessible under an open-access model, ensuring that cutting-edge research reaches a diverse audience and enhances knowledge in this critical field. As it continues to converge research from 2011 to 2024, the journal remains a cornerstone in the study of pharmaceutical evaluation, analytical methods, and their applications.

JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, published by Taylor & Francis Inc, is a pivotal platform for disseminating cutting-edge research in the field of liquid chromatography and its applications across various disciplines including analytical chemistry, biochemistry, and pharmaceutical science. With an ISSN of 1082-6076 and an E-ISSN of 1520-572X, this journal serves as an essential resource for researchers, professionals, and students committed to advancing the understanding and development of chromatographic techniques. Despite not being an open access publication, the journal features a robust submission process from 1996 to 2024, ensuring comprehensive coverage of historical and contemporary methodologies. Notably, it has achieved rankings in the Q3 and Q4 quartiles across various categories, reflecting its reputable position in the field. It’s recognized within key databases, with Scopus ranks indicating its influential role in areas such as pharmaceutical science and analytical chemistry. This journal is not only a cornerstone for specialized studies but also fosters interdisciplinary collaborations, making it an invaluable asset for the scientific community.

AAPS Journal, published by Springer in the United States, is a leading peer-reviewed journal dedicated to the advancement of research in the field of Pharmaceutical Sciences. With an impressive Q1 rank in its category and a position within the 81st percentile of Scopus rankings, it serves as a vital resource for researchers and professionals seeking to disseminate impactful findings and innovative methodologies. The journal publishes high-quality original research, review articles, and technical reports aimed at addressing the multifaceted challenges in pharmacology, toxicology, and pharmaceutics. Operating under an Open Access model, AAPS Journal ensures broad dissemination of knowledge, contributing to the enhanced visibility and accessibility of research outputs. With a publication window spanning from 1999 to 2024, it continues to shape the future of pharmaceutical research and its applications. Researchers, students, and industry professionals will find a valuable repository of cutting-edge knowledge in this esteemed journal.

PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.